Fludarabine
Retinoblastoma
Masonic Cancer Center, University of MinnesotaSmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
6 Active assets in the Retinoblastoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FILGRASTIM Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Phase 4 | BBB |
Itraconazole Samsung Medical Center | Phase 4 | BB |
Thiotepa Masonic Cancer Center, University of Minnesota | Phase 2 | BB |
Cyclophosphamide Seattle Children's Hospital | Phase 2 | BB |
Busulphan Masonic Cancer Center, University of Minnesota | Phase 2 | BB |
View all 29 →
Same molecule, other indications
Fludarabine is also rated in:
acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →